Prevalence and Treatment of New-Onset Diabetes Mellitus After Liver Transplantation in Korean Children: A Single-Center Study

• Published in: Transplantation proceedings Vol. 46; no. 3; pp. 873 - 875
• Main Authors: Cho, J.M, Oh, S.H, Kim, K.M, Namgung, J.M, Kim, D.Y, Song, G.W, Ha, T.Y, Moon, D.B, Ahn, C.S, Kim, K.H, Hwang, S, Lee, S.G
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2014
• Subjects: Adolescent; Child; Child, Preschool; Diabetes Mellitus - etiology; Female; Humans; Infant; Korea; Liver Transplantation - adverse effects; Male; Prevalence; Surgery; Korea
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2013.11.065

Abstract The aim of this study was to investigate the prevalence, clinical characteristics, and management of new-onset diabetes mellitus (NODM) in Korean children with liver transplantation (LT). We retrospectively analyzed the medical records of 200 pediatric patients (5 months to 17 years old) who underwent LT at Asan Medical Center between January 1994 and December 2010; 26 pediatric patients who died at the maximal follow-up after LT or who were lost to follow-up were excluded from the study. Among these 174 children, NODM after LT developed in 18. The median interval time at the presentation of NODM after LT was 15 days (range, 1 day to 16.0 years), whereas the median patient age of NODM diagnosis was 10 years (range, 1.1 to 17.0 years). Insulin treatment with reduction in tacrolimus dosage, steroid tapering, and conversion from tacrolimus to cyclosporine with or without mycophenolate mofetil is highly effective in NODM after LT. In conclusion, careful diabetes mellitus monitoring and modification of immunosuppressive regimen should be required in pediatric patients after LT.